ICU Medical Inc. (ICUI)
undefined
undefined%
At close: undefined
164.86
-0.12%
After-hours Jan 06, 2025, 04:00 PM EST

ICU Medical Inc. Revenue Breakdown

Quarter Sep 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023
Equipment revenue Revenue 38.83M 9.34M 0 25.62M 15.61M 17.46M
Equipment revenue Revenue Growth +315.69% n/a -100.00% +64.18% -10.64% n/a
Other deferred revenue Revenue 503.00K 0 0 944.00K 1.45M 1.42M
Other deferred revenue Revenue Growth n/a n/a -100.00% -34.94% +2.04% n/a
Software revenue Revenue 24.56M 155.00K 0 1.67M 2.59M 3.71M
Software revenue Revenue Growth +15744.52% n/a -100.00% -35.39% -30.18% n/a
Government Grant Revenue Revenue 7.86M 5.57M 0 12.80M 8.00M 8.32M
Government Grant Revenue Revenue Growth +41.16% n/a -100.00% +59.94% -3.87% n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017
Emea Revenue 373.57M 367.41M 147.49M 132.76M 130.53M 134.36M 30.18M
Emea Revenue Growth +1.68% +149.11% +11.09% +1.71% -2.85% +345.15% n/a
Other Foreign Countries Revenue 203.84M 195.31M 227.01M 227.61M 212.34M 211.00M 979.94M
Other Foreign Countries Revenue Growth +4.37% -13.96% -0.26% +7.20% +0.64% -78.47% n/a
United States Revenue 1.44B 1.46B 941.81M 910.63M 923.34M 1.05B n/a
United States Revenue Growth -1.37% +55.03% +3.42% -1.38% -12.45% n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 162.71M 159.55M 157.66M 154.62M 148.61M 150.90M 152.57M 142.93M 153.45M 158.75M 153.21M 81.46M 74.81M 73.92M 72.39M 73.55M 70.85M 67.24M 72.31M 70.65M 65.88M 67.82M 72.63M 79.54M 78.07M 83.54M 87.00M 77.14M 76.82M 85.11M 64.89M 22.60M 22.36M 22.49M 21.98M 22.52M 20.21M 20.32M 20.17M
Selling, General, and Administrative Revenue Growth +1.98% +1.20% +1.97% +4.04% -1.51% -1.10% +6.74% -6.85% -3.34% +3.61% +88.09% +8.88% +1.21% +2.11% -1.58% +3.81% +5.37% -7.00% +2.34% +7.25% -2.87% -6.62% -8.69% +1.89% -6.55% -3.98% +12.78% +0.42% -9.74% +31.16% +187.13% +1.06% -0.57% +2.35% -2.42% +11.45% -0.55% +0.71% n/a
Research and Development Revenue 21.03M 23.39M 21.84M 22.41M 20.87M 22.30M 19.76M 23.45M 23.11M 22.56M 23.87M 13.17M 12.24M 11.38M 10.71M 11.80M 10.13M 10.28M 10.75M 12.59M 12.00M 11.20M 12.82M 13.53M 13.18M 13.57M 12.59M 13.88M 12.77M 12.97M 11.64M 2.65M 3.65M 3.34M 3.31M 4.06M 4.23M 3.12M 4.31M
Research and Development Revenue Growth -10.10% +7.09% -2.54% +7.38% -6.42% +12.86% -15.72% +1.48% +2.41% -5.48% +81.31% +7.58% +7.49% +6.31% -9.22% +16.50% -1.49% -4.35% -14.63% +4.87% +7.17% -12.66% -5.19% +2.61% -2.90% +7.86% -9.30% +8.67% -1.53% +11.39% +338.62% -27.29% +9.35% +0.75% -18.34% -4.02% +35.39% -27.53% n/a